Pakistan has the intellectual capital, institutional foundation and market potential to achieve vaccine independence. What we ...

The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

In a recent Q&A hosted by Susan Thornton, CEO of the Cutaneous Lymphoma Foundation, a patient advocacy group, Dr. Kim shared her gratitude to clinical trial participants and emphasized the urgent need ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...

Biontech SE and Bristol Myers Squibb Co. are teaming up to develop Biontech’s bispecific antibody targeting PD-L1 and VEGF-A, BNT-327, in a deal possibly worth over $11 billion. The companies will ...

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

The Department of Health and Human Services (HHS) has canceled funding pledged to Moderna for the development of mRNA-based ...